Celltrion Healthcare’s ‘Herzuma’ had first prescription in Germany

‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, Celltrion Healthcare is actively selling in the world had the first prescription in Germany as it did in the U.K.

Thus, ‘Herzuma’ has been sold in Germany, one of the Big 5 European countries for the first time as a trastuzumab biosimilar. The company explained this as a result o...